Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
105,632,895
-
Total 13F shares
-
71,710,913
-
Share change
-
+1,661,842
-
Total reported value
-
$10,889,813,246
-
Put/Call ratio
-
91%
-
Price per share
-
$151.95
-
Number of holders
-
359
-
Value change
-
+$292,081,135
-
Number of buys
-
178
-
Number of sells
-
169
Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q2 2019
As of 30 Jun 2019 Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) had 359 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 71,710,913 shares of stock of the company.
Largest 10 holders included FMR LLC, VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, SANDS CAPITAL MANAGEMENT, LLC, JANUS HENDERSON GROUP PLC, Invesco Ltd., FIL Ltd, Avoro Capital Advisors LLC, and STATE STREET CORP.
This table shows 359 institutional shareholders of the security as of 30 Jun 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.